[go: up one dir, main page]

DE69229572D1 - Gliazellen-aktivierender Faktor und dessen Herstellung - Google Patents

Gliazellen-aktivierender Faktor und dessen Herstellung

Info

Publication number
DE69229572D1
DE69229572D1 DE69229572T DE69229572T DE69229572D1 DE 69229572 D1 DE69229572 D1 DE 69229572D1 DE 69229572 T DE69229572 T DE 69229572T DE 69229572 T DE69229572 T DE 69229572T DE 69229572 D1 DE69229572 D1 DE 69229572D1
Authority
DE
Germany
Prior art keywords
activating factor
glia activating
glial cell
glia
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69229572T
Other languages
English (en)
Other versions
DE69229572T2 (de
Inventor
Ken-Ichi Naruo
Chisako Seko
Tsutomu Kurokawa
Tatsuya Kondo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DE69229572D1 publication Critical patent/DE69229572D1/de
Publication of DE69229572T2 publication Critical patent/DE69229572T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69229572T 1991-02-14 1992-02-13 Gliazellen-aktivierender Faktor und dessen Herstellung Expired - Lifetime DE69229572T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2086091 1991-02-14
JP22445491 1991-09-04
JP00339992A JP3385040B2 (ja) 1991-02-14 1992-01-10 グリア活性化因子およびその製造法

Publications (2)

Publication Number Publication Date
DE69229572D1 true DE69229572D1 (de) 1999-08-19
DE69229572T2 DE69229572T2 (de) 1999-11-11

Family

ID=27275805

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69229572T Expired - Lifetime DE69229572T2 (de) 1991-02-14 1992-02-13 Gliazellen-aktivierender Faktor und dessen Herstellung

Country Status (6)

Country Link
US (2) US5512460A (de)
EP (1) EP0503297B1 (de)
JP (1) JP3385040B2 (de)
AT (1) ATE182174T1 (de)
CA (1) CA2061148C (de)
DE (1) DE69229572T2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840836A (en) * 1989-02-17 1998-11-24 Bayer Corporation Pancreatic islet cell antigens obtained by molecular cloning
US6811989B1 (en) * 1989-02-17 2004-11-02 Bayer Corporation Pancreatic islet cell antigens obtained by molecular cloning
EP0585631A1 (de) * 1992-08-05 1994-03-09 Takeda Chemical Industries, Ltd. Blutplättchen vermehrendes Agens
EP0608546A3 (en) * 1992-12-22 1995-09-27 Takeda Chemical Industries Ltd Glia activating factor (gaf), antibodies against it and their uses.
CA2115522A1 (en) * 1993-02-12 1994-08-13 Takeda Pharmaceutical Company Limited Hst-2 mutein, dna coding for the same and preparation thereof
US5922572A (en) 1994-01-25 1999-07-13 Human Genome Sciences, Inc. Polynucleotides encoding haemopoietic maturation factor
US6447783B1 (en) * 1995-06-12 2002-09-10 Yeda Research And Development Co., Ltd. Compositions comprising FGF9 and use thereof for stimulating cartilage and bone repair
US5731284A (en) * 1995-09-28 1998-03-24 Amgen Inc. Method for treating Alzheimer's disease using glial line-derived neurotrophic factor (GDNF) protein product
WO1998029547A1 (en) * 1996-12-31 1998-07-09 The Rockefeller University Modulators of radial glia-astrocyte differentiation and transformation, and diagnostic and therapeutic uses thereof
WO1999013074A1 (fr) * 1997-09-08 1999-03-18 Taisho Pharmaceutical Co., Ltd. Proteine activant des fonctions de cellules nerveuses
US20010006939A1 (en) * 1997-10-03 2001-07-05 Ralph W. Niven Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions
US7056885B1 (en) * 1999-07-27 2006-06-06 Curagen Corporation Fibroblast growth factor and nucleic acids encoding same
US20020058036A1 (en) * 1999-07-27 2002-05-16 Michael Jeffers Novel fibroblast growth factor and nucleic acids encoding same
US7291483B2 (en) 1999-07-27 2007-11-06 Curagen Corporation FGF-CX polynucleotide sequences and methods of producing same
IL139380A0 (en) * 2000-10-31 2001-11-25 Prochon Biotech Ltd Active variants of fibroblast growth factor
US6982250B2 (en) 2000-11-06 2006-01-03 Curagen Corporation Methods of prevention and treatment of inflammatory bowel disease
IL149562A0 (en) 2002-05-09 2002-11-10 Prochon Ltd Fgf variants and methods for use thereof
US7067123B2 (en) * 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
WO2007035778A2 (en) 2005-09-19 2007-03-29 Histogenics Corporation Cell-support matrix and a method for preparation thereof
CA2664921A1 (en) 2006-09-28 2008-04-03 Hepacore Ltd. N-terminal fgf variants having increased receptor selectivity and uses thereof
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
US20090054984A1 (en) 2007-08-20 2009-02-26 Histogenics Corporation Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects
US8685107B2 (en) 2007-07-03 2014-04-01 Histogenics Corporation Double-structured tissue implant and a method for preparation and use thereof
WO2009111069A1 (en) 2008-03-05 2009-09-11 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
WO2012038953A2 (en) 2010-09-21 2012-03-29 Hepacore Ltd. Fgf-18 truncated variants having increased receptor specificity and uses thereof
WO2012140650A2 (en) 2011-04-12 2012-10-18 Hepacore Ltd. Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
US20210395678A1 (en) 2018-11-08 2021-12-23 Integriculture Inc. Animal cell growth promoter, culture medium for animal cell culture, and animal cell culture apparatus

Also Published As

Publication number Publication date
EP0503297A1 (de) 1992-09-16
ATE182174T1 (de) 1999-07-15
DE69229572T2 (de) 1999-11-11
JPH05301893A (ja) 1993-11-16
JP3385040B2 (ja) 2003-03-10
CA2061148A1 (en) 1992-08-15
US5512460A (en) 1996-04-30
CA2061148C (en) 2004-08-24
EP0503297B1 (de) 1999-07-14
US5622928A (en) 1997-04-22

Similar Documents

Publication Publication Date Title
DE69229572D1 (de) Gliazellen-aktivierender Faktor und dessen Herstellung
EP0404034A3 (de) DNS und ihre Verwendung
ATE45382T1 (de) Biosynthetisch hergestellter humannervenwachstumsfaktor, verfahren zu seiner herstellung, diesen faktor enthaltende zusammensetzungen, diesen faktor codierende dna- sequenz, vektoren, die diese sequenz enthalten und dadurch transformierte wirtszellen.
CA2127463A1 (en) Biodegradable polymers for cell transplantation
ATE275197T1 (de) Glial neurotrophe faktor
GR3032790T3 (en) Materials and methods for hypersecretion of amino acids
ATE123295T1 (de) Rezeptor-proteine für humanen b-zellen stimulierenden faktor 2.
DK1396542T3 (da) P-selectin ligand protein
CA2001303A1 (en) Endothelin dna and use thereof
CA2180103A1 (en) Gene encoding adseverin
AU4683489A (en) Tgf-beta 1/beta 2: a novel chimeric transforming growth factor-beta
CA2011833A1 (en) Novel polypeptide and production thereof
WO1995030001A3 (en) Novel p-selectin ligand protein
EP0649900A3 (de) Verfahren zur Herstellung von Proteinen.
EP0251730A3 (de) Herstellung von menschlichem Lysozym
DE3854420D1 (de) Onkogen kodierendes polypeptid, das wachstumsfaktoraktivität besitzt, verfahren zu seiner herstellung und verwendung.
DE69305826D1 (de) Verfahren zur Herstellung von Alkalimetallcitrat
ES2088911T3 (es) Gen de la proteasa i de achromobacter y el producto de este gen.
ATE84065T1 (de) Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i.
ATE60359T1 (de) Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung.
ATE346941T1 (de) Protein-disulfidisomerase-gen eines methylotrophen hefestammes
AU6860294A (en) New chondrocyte proteins
Yin et al. Fermentation process.
Shiio et al. Process for the production of L-threonine by fermentation.
EP0477791A3 (en) Polypeptide

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: TAKEDA PHARMACEUTICAL CO. LTD., OSAKA, JP